A Phase II, fixed-sequenced, open- label, research study to assess pharmacokinetic drug interactions of AEGR-733 on lipid-lowering therapies in healthy volunteers.
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Lomitapide (Primary) ; Atorvastatin; Dextromethorphan; Ezetimibe; Fenofibrate; Niacin; Simvastatin
- Indications Hyperlipoproteinaemia type IIa
- Focus Pharmacokinetics
- Sponsors Aegerion Pharmaceuticals
- 13 Oct 2009 Actual patient number (125) added as reported by ClinicalTrials.gov.
- 13 Oct 2009 Actual end date (Nov 2007) added as reported by ClinicalTrials.gov.
- 07 Nov 2006 New trial record.